Ketoprofen spray-dried microspheres based on eudragit® RS and RL: Study of the manufacturing parameters

Drug Development and Industrial Pharmacy

Volumn 34, Issue 11, 2008, Pages 1178-1187

  Rassu, Giovanna ^a   Gavini, Elisabetta ^a   Spada, Gianpiera ^a   Giunchedi, Paolo ^a   Marceddu, Salvatore ^b  

^a UNIVERSITY OF SASSARI   (Italy)

^b INSTITUTE OF SCIENCES OF FOOD PRODUCTION   (Italy)

Author keywords

Eudragit ; Ketoprofen; Microspheres; Spray drying parameters

Indexed keywords

EUDRAGIT; KETOPROFEN; MICROSPHERE; POLYMER;

ARTICLE; CRYSTALLIZATION; DRUG FORMULATION; DRUG MANUFACTURE; DRUG STORAGE; DRUG SYNTHESIS; NEBULIZATION; PARTICLE SIZE; SPRAY DRYING;

ACRYLIC RESINS; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; KETOPROFEN; MICROSPHERES; PARTICLE SIZE;

EID: 54349108663     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040801974303     Document Type: Article

References (45)

1. Caruso, I., Frigerio, E., Fumagalli, M., Liverta, C., Moro, L., & Tamassia, V. (1982). Bioavailability study on a new slow-release formulation of ketoprofen. J. Int. Med. Res., 10, 229-233.
2. Castelli, F., Conti, B., Maccarrone, D. E., Conte, U., & Puglisi, G. (1998). Comparative study of 'in vitro' release of anti-inflammatory drugs from polylactide-co-glycolide microspheres. Int. J. Pharm., 176, 85-98.
3. Castelli, F., Messina, C., Sarpietro, M. G., Pignatello, R., & Puglisi, G. (2002). Flurbiprofen release from Eudragit RS and RL aqueous nanosus-pensions: A kinetic study by DSC and dialysis experiments. AAPS PharmSciTech, 3, 1-8.
4. Chan, H-K., & Chew, N. Y. K. (2003). Novel alternative methods for the delivery of drugs for the treatment of asthma. Adv. Drug Deliv. Rev., 55, 793-805.
5. El-Gibaly, I. (2002). Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery. Int. J. Pharm., 232, 199-211.
6. El-Kamel, A. H., Sokar, M. S., Al Gamal, S. S., & Naggar, V. F., 2001. Preparation and evaluation of ketoprofen floating oral delivery system. Int. J. Pharm., 220, 13-21.
7. Esposito, E., Roncarati, R., Cortesi, R., Cervellati, F., & Nastruzzi, C. (2000). Production of eudragit microparticles by spray-drying technique: Influence of experimental parameters on morphological and dimensional characteristics. Pharm. Dev. Technol., 5, 267-278.
8. Gabor, F., Ertl, B., Wirth, M., & Mallinger, R. (1999). Ketoprofen-poly(D,L-lactic-co-glicolic acid) microspheres: Influence of manufacturing parameters and type of polymer on the release characteristics. J. Microencapsul., 16, 1-12.
9. Gavini, E., Sanna, V., Juliano, C., & Giunchedi, P. (2003). Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen. J. Microencapsul., 20, 193-201.
10. Genta, I., Perugini, P., Conti, B., & Pavanetto, F. (1997). A multiple emulsion method to entrap a lipophilic compound into chitosan microspheres. Int. J. Pharm., 152, 237-246.
11. Giunchedi, P., & Conte, U. (1995). Spray-drying as a preparation method of microparticulate drug delivery systems: An overview. S.T.P. Pharm. Sci., 5, 276-290.
12. Giunchedi, P., Conte, U., Chetoni, P., & Saettone, M. F. (1999). Pectin microspheres as ophthalmic carriers for piroxicam: Evaluation in vitro and in vivo in albino rabbits. Eur. J. Pharm. Sci., 9, 1-7.
13. Giunchedi, P., Conti, B., Maggi, L., & Conte, U. (1994). Cellulose acetate butyrate and polycaprolactone for ketoprofen spray-dried microsphere preparation. J. Microencapsul., 11, 381-393.
14. Giunchedi, P., Gavini, E., Bonacucina, G., & Palmieri, G. F. (2000). Tabletted polylactide microspheres prepared by a w/o emulsion-spray drying method. J. Microencapsul., 17, 711-720.
15. Giunchedi, P., Maggi, L., Conte, U., & Caramella, C. (1991). Ketoprofen pulsatile absorption from 'multiple unit' hydrophilic matrices. Int. J. Pharm., 77, 177-181.
16. Goto, S., Kawata, M., Nakamura, M., Maekauwa, K., & Ayoama, T. (1986). Eudragit RS and RL (acrylic resins) micro-capsules as pH insensitive and sustained release prepara-tions of ketoprofen. J. Microencapsul., 3, 293-304.
17. Habib, M. J., & Meuse, R. (1995). Development of controlled release formulations of ketorpofen for oral use. Drug. Dev. Ind. Pharm., 21, 1463-1472.
18. Haznedar, S., & Dortunç, B. (2004). Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int. J. Pharm., 269, 131-140.
19. Houghton, G. W., Dennis, M. J., Rigler, E. D., & Parsons, R. L. (1984). Comparative pharmacokinetics of ketoprofen derived from single oral doses of ketoprofen capsules or a novel sustained-release pellet formulation. Biopharm. Drug Dispos., 5, 203-209.
20. Houghton, G. W., Dennis, M. J., Templelon, R., Calvert, R. M., & Cresswell, D. G. (1984). A pharmacokinetic study of repeated doses of a new controlled release of ketoprofen. Int. J. Clin. Pharmacol. Ther., 23, 131-133.
21. Kawashima, Y., Niwa, T., Handa, T., Takeuchi, H., & Ito, Y. (1991). Preparation and characterization of a new controlled re-lease ibuprofen suspension for improving suspendability. Int. J. Pharm., 75, 25-36.
22. Kawashima, Y., Niwa, T., Handa, T., Takeuchi, H., Iwamoto, T., & Ito, Y. (1989). Preparation of prolonged-release spheri-cal micromatrix of ibuprofen with acrylic polymer by the emulsion solvent diffusion method for improving bioavailability. Chem. Pharm. Bull., 37, 425-429.
23. Kawashima, Y., Toshiyuki, H., Takeuchi, H., Hino, T., & Ito, Y. (1992). Control of prolonged drug release and compression properties of ibuprofen microsponges with acrylic poly-mer; Eudragit RS, changing their intrapartical porosity. Chem. Pharm. Bull., 40, 196-201.
24. Kawata, M., Nakamura, M., Goto, T., & Ayoama, T. (1968). Preparation and dissolution pattern of Eudragit RS microcapsules containing Ketoprofen. Chem. Pharm. Bull., 34, 2618-2623.
25. Khalil, E., & Sallam, A. (1999). Interaction of two Diclofenac acid salts with copolymers of ammoniomethacrylate: Effect of additives and release profiles. Drug. Dev. Ind. Pharm., 25, 419-427.
26. Khan, M. A., Dib, J., & Reedy, I. K. (1996). Statistical optimization of ketoprofen Eudragit S100 coprecipitates to obtain controlled release tablets. Drug. Dev. Ind. Pharm., 22, 135-141.
27. Le Liboux, A., Teule, M., Frydman, A., Osterhuis, B., & Jonkman, J. H. G. (1994). Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen. Eur. J. Clin. Pharmacol., 47, 361-366.
28. Marcolongo, R., Rubegni, M., Provvedi, D., Giordano, N., Frati, E., & Bruni, G. (1984). A double-blind, interpatient comparison of plain and slow-release ketoprofen in osteoarthritis. Int. J. Clin. Pharmacol. Ther., 22, 377-381.
29. Masters, K. (1991). The spray drying handbook. New York, USA: Longman Scientific and Technical.
30. Mateovic-Rojnik, T., Frlan, R., Bogataj, M., Bukovec, P., & Mrhar, A. (2005). Effect of preparation temperature in solvent evaporation process on Eudragit RS microsphere properties. Chem. Pharm. Bull., 53, 143-146.
31. Meier, C. (2005, April). Phisico chemical properties of Eudragit® polymers and their influences on film properties. Conference paper presented at 47th Eudragit International Workshop, Darmstadt, Germany.
32. Moretti, M. D. L., Gavini, E., Juliano, C., Pirisino, G., & Giunchedi, P. (2001). Spray-dried microspheres containing ketoprofen formulated into capsules and tablets. J. Microencapsul., 18, 111-121.
33. Morley, K. D., Bernstein, R. M., Hughes, G. R. V., Black, C. M., Rajapakse, C. A. N., & Wilson, L. (1984). A comparative trial of a controlled-release formulation of ketoprofen ('oruvail') and a conventional capsule formulation of ketoprofen ('orudis') in patients with osteoarthritis of the hip. Curr. Med. Res. Opin., 9, 28-34.
34. Omari, D. M., Sallam, A., Abd-Elbary, A., & El-Samaligy, M. (2004). Lactic acid-induced modifications in films of Eudragit RL and RS aqueous dispersions. Int. J. Pharm., 274, 85-96.
35. Palmieri, G. F., Bonacucina, G., Di Martino, P., & Martelli, S. (2002a). Gastro-resistant microspheres containing ketoprofen. J. Microencapsul., 19, 111-119.
36. Palmieri, G. F., Bonacucina, G., Di Martino, P., & Martelli, S. (2002b). Microencapsulation of semisolid ketoprofen/polymer microspheres. Int. J. Pharm., 242, 175-178.
37. Palmieri, G. F. (Chair), Elisei, I., Di Martino, P., & Martelli, S. (2000, April). Formulation of microparticulate systems for modified release containing ketoprofen. Conference paper presented at the 19th Pharmaceutical Technology Conference. Baveno-Stresa, Italy.
38. Palmieri, G. F., Martelli, S., Lauri, D., & Wehrle, P. (1996). Gelatin-acacia complex coacervation as a method for ketoprofen microencapsulation. Drug Dev. Ind. Pharm., 22, 951-957.
39. Parejo, C., Gallardo, A., & San Roman, J. (1998). Controlled release of NSAIDs bound to polyacrylic carrier systems. J. Mater. Sci. Mater. Med., 9, 803-809.
40. Pignatello, R., Vandelli, M. A., Giunchedi, P., & Puglisi, G. (1997). Properties of Tolmetin-loaded Eudragit RL100 and RS100 microparticles prepared by different techniques. STP Pharm. Sci., 7, 148-157.
41. Ré, M. I., & Biscans, B. (1999). Preparation of microspheres of ketoprofen with acrylic polymers by a quasi-emulsion solvent diffusion method. Powder Technol., 101, 120-133.
42. Ricci, M., Blasi, P., Giovagnoli, S., Rossi, C., Macchiarulo, G., Luca, G., Basta, G., & Calafiore, R. (2005). Ketoprofen controlled release from composite microcapsules for cell encapsulation: Effect on post-transplant acute inflammation. J. Control. Release, 107, 395-407.
43. Roda, A., Sabatini, L., Mirasoli, M., Baraldini, M., & Roda, E. (2002). Biovailability of a new ketoprofen formulation for once-daily oral administration. Int. J. Pharm., 241, 165-172.
44. Vergote, G. J., Vervaet, C., Van Driessche, I., Hoste, S., De Smedt, S., Demeester, J., Jain, R. A., Ruddy, S., & Remon, J. P. (2001). An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int. J. Pharm., 219, 81-87.
45. Vueba, M. L., Batista de Carvalho, L. A. E., Veiga, F., Sousa, J. J., & Pina, M. E. (2004). Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eur. J. Pharm. Biopharm., 58, 51-59.